As European markets show resilience, with the STOXX Europe 600 Index gaining ground amid solid economic data and earnings results, investors are increasingly looking for opportunities in value stocks that may be trading below their intrinsic worth. In this environment, identifying stocks with strong fundamentals and potential for growth can offer a strategic advantage to those seeking to capitalize on market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| Streamwide (ENXTPA:ALSTW) |
€71.80 |
€142.62 |
49.7% |
| Ryvu Therapeutics (WSE:RVU) |
PLN26.00 |
PLN51.71 |
49.7% |
| Nexstim (HLSE:NXTMH) |
€12.15 |
€24.04 |
49.5% |
| Matica Fintec (BIT:MFT) |
€1.83 |
€3.61 |
49.4% |
| Honkarakenne Oyj (HLSE:HONBS) |
€2.64 |
€5.18 |
49.1% |
| Doxee (BIT:DOX) |
€3.73 |
€7.43 |
49.8% |
| DO & CO (WBAG:DOC) |
€203.00 |
€399.18 |
49.1% |
| DigiTouch (BIT:DGT) |
€1.98 |
€3.90 |
49.3% |
| B&S Group (ENXTAM:BSGR) |
€5.85 |
€11.66 |
49.8% |
| Allcore (BIT:CORE) |
€1.335 |
€2.65 |
49.5% |
Here we highlight a subset of our preferred stocks from the screener.
I.CO.P.. Società Benefit
Overview:I.CO.P. S.p.A. Società Benefit offers construction services to both public and private clients across Italy, the European Union, and internationally, with a market cap of €581.54 million.
Operations:The company's revenue segment is primarily focused on heavy construction, generating €155.27 million.
Estimated Discount To Fair Value:25%
I.CO.P. Società Benefit is trading at €18.3, below its estimated fair value of €24.41, making it undervalued based on discounted cash flows. The company has experienced an 87.8% earnings growth over the past year and forecasts suggest a continued robust annual profit growth rate of 32.7%, outpacing the Italian market's 9.2%. However, its debt coverage by operating cash flow is inadequate, which could pose financial challenges despite high revenue growth expectations of 38.1% annually.
Arlandastad Group
Overview:Arlandastad Group AB (publ) is a Swedish real estate development company with a market cap of SEK3.03 billion.
Operations:The company's revenue is derived from Operating Activities (SEK170.65 million), Property Improvement (SEK9.32 million), and Management of Properties (SEK212.07 million).
Estimated Discount To Fair Value:27.5%
Arlandastad Group, trading at SEK 47.9, is undervalued based on discounted cash flows with a fair value estimate of SEK 66.09. Its earnings are forecast to grow significantly at 42.6% annually, surpassing the Swedish market's growth rate of 13%. Despite low future return on equity and large one-off items affecting results, recent M&A activity by Samhällsbyggnadsbolaget i Norden AB highlights investor interest with a stake acquisition at SEK 42 per share.
RaySearch Laboratories
Overview:RaySearch Laboratories AB (publ) is a medical technology company that offers software solutions for cancer treatment globally, with a market cap of SEK7.32 billion.
Operations:RaySearch Laboratories generates revenue primarily from its healthcare software segment, which accounted for SEK1.29 billion.
Estimated Discount To Fair Value:20%
RaySearch Laboratories, trading at SEK 213.5, is undervalued with a fair value estimate of SEK 266.96 based on discounted cash flows. Recent earnings growth and strategic client expansions into proton therapy enhance its financial outlook. The company forecasts significant annual profit growth of 24.3%, outpacing the Swedish market's rate of 13%. However, revenue growth at 13.9% annually remains below the threshold for high expectations but surpasses the broader market's pace.
Summing It All Up
-
Explore the 208 names from our Undervalued European Stocks Based On Cash Flows screener here.
-
Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St , where we make it simple for investors like you to stay informed and proactive.
-
Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.
Ready To Venture Into Other Investment Styles?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BIT:ICOP OM:AGROUP and OM:RAY B.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
